Skip to Content

GG 367 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg)

Pill imprint GG 367 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg.

Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg / 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Benazepril hydrochloride and hydrochlorothiazide 20 mg / 25 mg GG 367
Benazepril hydrochloride and hydrochlorothiazide
GG 367
20 mg / 25 mg
Elliptical / Oval
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
33358-0050 CorePharma, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.